A collaborative investigation by researchers at Brigham and Women's Hospital and Johns Hopkins University created a cancer treatment that utilizes mesenchymal stem cells and microparticles. Both components of the treatment are engineered to specifically target and kill cancer cells.
A new advancement in stem cell differentiation has been developed by UNSW Australia researchers. The technique utilizes autologous stem cells treated with a series of growth factors to promote cell plasticity. The mixture is then inserted into damaged tissues, promoting growth and healing.
Researchers at the University of Miami Miller School of Medicine have found that age has a profound effect on the efficacy of transplanted mesenchymal stem cell therapy. A series of previous studies had shown that stem cells could repair damage done to lungs caused by pulmonary fibrosis, but those studies relied on donor cells from relatively young animals. This study examined the differences in young and old stem cells, finding substantial differences in their biological utility.